Back to Search Start Over

Are GABAA Receptors Containing α5 Subunits Contributing to the Sedative Properties of Benzodiazepine Site Agonists?

Authors :
Savić, Miroslav M.
Shengming Huang
Furtmüller, Roman
Clayton, Terry
Huck, Sigismund
Obradović, Dragan I
Ugrešić, Nenad D
Sieghart, Werner
Bokonjić, Dubravko R.
Cook, James M.
Source :
Neuropsychopharmacology; Jan2008, Vol. 33 Issue 2, p332-339, 8p, 1 Diagram, 5 Graphs
Publication Year :
2008

Abstract

Classical benzodiazepines (BZs) exert anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsive, and amnesic effects through potentiation of neurotransmission at GABA<subscript>A</subscript> receptors containing α<subscript>1</subscript>, α<subscript>2</subscript>, α<subscript>3</subscript> or α<subscript>5</subscript> subunits. Genetic studies suggest that modulation at the α<subscript>1</subscript> subunit contributes to much of the adverse effects of BZs, most notably sedation, ataxia, and amnesia. Hence, BZ site ligands functionally inactive at GABA<subscript>A</subscript> receptors containing the α<subscript>1</subscript> subunit are considered to be promising leads for novel, anxioselective anxiolytics devoid of sedative properties. In pursuing this approach, we used two-electrode voltage clamp experiments in Xenopus oocytes expressing recombinant GABA<subscript>A</subscript> receptor subtypes to investigate functional selectivity of three newly synthesized BZ site ligands and also compared their in vivo behavioral profiles. The compounds were functionally selective for α<subscript>2</subscript>-, α<subscript>3</subscript>-, and α<subscript>5</subscript>-containing subtypes of GABA<subscript>A</subscript> receptors (SH-053-S-CH3 and SH-053-S-CH3-2′F) or essentially selective for α<subscript>5</subscript> subtypes (SH-053-R-CH3). Possible influences on behavioral measures were tested in the elevated plus maze, spontaneous locomotor activity, and rotarod test, which are considered primarily predictive of the anxiolytic, sedative, and ataxic influence of BZs, respectively. The results confirmed the substantially diminished ataxic potential of BZ site agonists devoid of α<subscript>1</subscript> subunit-mediated effects, with preserved anti-anxiety effects at 30 mg/kg of SH-053-S-CH3 and SH-053-S-CH3-2′F. However, all three ligands, dosed at 30 mg/kg, decreased spontaneous locomotor activity, suggesting that sedation may be partly dependent on activity mediated by α<subscript>5</subscript>-containing GABA<subscript>A</subscript> receptors. Hence, it could be of importance to avoid substantial agonist activity at α<subscript>5</subscript> receptors by candidate anxioselective anxiolytics, if clinical sedation is to be avoided.Neuropsychopharmacology (2008) 33, 332–339; doi:10.1038/sj.npp.1301403; published online 28 March 2007 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0893133X
Volume :
33
Issue :
2
Database :
Complementary Index
Journal :
Neuropsychopharmacology
Publication Type :
Academic Journal
Accession number :
27798809
Full Text :
https://doi.org/10.1038/sj.npp.1301403